Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
Total Funding: $4M
Total Funding:
Total Funding:
Total Funding: $5M
Total Funding: $15K
Total Funding: $22M
Total Funding: $250K
Total Funding: $5.3M
Total Funding:
Total Funding: $2M
2023
The Terasaki Institute for Biomedical Innovation envisions a world where personalized medicine is available to all. Every person is unique with individual challenges to optimal health, from genetic predisposition to disease to socioeconomic barriers to care. We strive to address those challenges to bridge the gap between sickness and wellness. The Terasaki Institute for Biomedical Innovation aims to tackle the biggest problems in health. We are focused on solving problems in new ways, developing ‘personalized’ solutions, prototyping tangible solutions, and bringing our innovation to the real-world.
2022
2022
2021
2021
Omeat is a food startup that has pioneered a scalable way to produce cultivated meat that’s delicious, affordable, orders-of-magnitude more sustainable than conventional meat, and doesn’t involve sacrificing an animal. The secret to Omeat is a proprietary process that harnesses the intrinsically regenerative factors within cows' plasma to foster cell growth. Omeat’s growth media is a cost-effective alternative to fetal bovine serum and can be used to cultivate any kind of meat. Omeat is based in Los Angeles, founded in 2020 by world-renown tissue biologist Dr. Ali Khademhosseini. The company is currently building a pilot plant and rapidly expanding its team toward commercial readiness.
2021
We have developed platform technologies to genetically engineer, manufacture and purify cell-free vesicles that can control immune cell activation. Our first-in-class modality has the potential to treat a range of immunopathologies including inflammation, autoimmune diseases and cancers. Our platform works by signaling through validated targets for which biologics like agonistic antibodies are either unsafe or perform poorly. No other modality can fully recapitulate natural cell-to-cell signaling. To Faster Cures! 🚀🚀
2021
VistaPath Biosystems is modernizing pathology labs using machine augmentation. Despite informing a majority of clinical decisions, anatomical pathology still prepares samples for diagnosis manually, in stark contrast to other clinical lab services. Driven by computer vision, we have developed a Workflow Management System which relieves highly paid technicians from manual tissue processing
2020
2020
AI Sprouts provides capital, technology and business services to AI-Driven Startups with partnerships with academia, industry, technology, partners, mentors, and other investors
2015
YPO (Young Presidents’ Organization) is a not-for-profit, global network of chief executives connected around the shared mission of becoming Better Leaders Through Education and Idea Exchange™. Founded in 1950, YPO today provides 22,000 peers and their families in more than 125 countries with access to unique experiences, extraordinary educational resources, access to alliances with leading institutions, and participation in specialized networks to support their business, community and personal leadership. Altogether, YPO member-run companies employ more than 15 million people around the world and generate US$6 trillion in annual revenues.
2014
2014
Our mission is to make local delivery efficient and delightful. Onfleet makes it easy for businesses to manage and analyze their delivery operations. Our product includes a clean web dashboard, rich APIs, out-of-the-box driver apps for iOS and Android, and customer notifications, accurate ETAs and a map that lets recipients track their orders in realtime. Our customers include food, beverage, and grocery delivery businesses as well as home services and local couriers. Onfleet is based in San Francisco, California, and was accelerated by StartX
2022
2022
Saas-Based Identity Management Services Are The “Front Door” To Any Organization. Services from: Okta, AzureAD, Google Identity, and others are foundational in any modern organization. These services are responsible for: * User identity management and authentication * Application access and assignment * Security and compliance policies, etc. However, while being mission-critical for any customer, these services are a single point of failure. While the Cloud (Service) Provider is responsible for service SLA, customers are responsible for their own data and its integrity. accSenSe’s mission is to provide you and your customers with SaaS resilience and peace of mind.
2015 - 2020
2015 - 2020